Genbiotech is strengthening its investment on its unique encapsulation device for rheumatology and aesthetic.
An 80 m2 controlled atmosphere structure that is totally equipped for the production of clinical batches microparticles is now functional.
This project is supported by the « Programme d’investissement d’avenir ».
Last update : 31/01/17